Molecular imaging of the breast

American Journal of Roentgenology

Volumn 193, Issue 2, 2009, Pages 367-376

  Birdwell, Robyn L ^a   Mountford, Carolyn E ^a   Iglehart, J Dirk ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Breast cancer; Breast cancer screening; Molecular imaging; MR spectroscopy; Nuclear medicine

Indexed keywords

ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; IODINATED CONTRAST MEDIUM; LAPATINIB; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PROGESTERONE RECEPTOR; PROTEIN TYROSINE KINASE INHIBITOR; RNA; TAMOXIFEN; TRASTUZUMAB;

ASPIRATION BIOPSY; BREAST CANCER; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GENETICS; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; DNA HYBRIDIZATION; DRUG TARGETING; FIBROADENOMA; GAMMA RADIATION; GENE EXPRESSION PROFILING; GENOTYPE; HUMAN; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MAMMOGRAPHY; MEDICAL CARE; METASTASIS; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; RNA HYBRIDIZATION; SCINTIMAMMOGRAPHY; SINGLE NUCLEOTIDE POLYMORPHISM; SPECTROSCOPY; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VASCULARIZATION;

ADULT; AGED; BIOPSY; BREAST; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL; DIAGNOSIS, DIFFERENTIAL; FALSE POSITIVE REACTIONS; FEMALE; FIBROMA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE SPECTROSCOPY; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; POSITRON-EMISSION TOMOGRAPHY; REFERENCE VALUES;

EID: 68149126136     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.09.3079     Document Type: Review

References (64)

1. Wagenaar DJ, Weissleder R, Hengerer A. Glossary of molecular imaging terminology. Acad Radiol 2001; 8:409-420
2. Hoffman JM, Gambhir SS. Molecular imaging: the vision and opportunity for radiology in the future. Radiology 2007; 244:39-47 (Pubitemid 46981957)
3. Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286:531-537
4. Perou CM, Sorlie T, Elsen MB, et al. Molecular portraits of human breast tumours. Nature 2000; 406:747-753
5. Lockhart DJ, Winzeler EA. Genomics, gene expression and DNA arrays. Nature 2000; 405:827-836 (Pubitemid 30407861)
6. Gresham D, Dunham MJ, Botstein D. Comparing whole genomes using DNA microarrays. Nat Rev Genet 2008; 9:291-302
7. Chin K, DeVries S, Fridlyand J, et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Res 2006; 10:529-541 (Pubitemid 44854748)
8. Osborne CK. Tamoxifen in the treatment of breast cancer. N Engl J Med 1998; 339:1609-1618
9. Dowsett M, Dunbier AK. Emerging biomarkers and new understanding of traditional markers in personalized therapy of breast cancer. Clin Cancer Res 2008; 14:8019-8026
10. Wang ZC, Lin M, Wei L-J, et al. Loss of heterozygosity and its correlation with expression profiles in subclasses of invasive breast cancers. Cancer Res 2004; 64:64-67
11. Lu X, Lu X, Wang ZC, Iglehart JD, Zhang X, Richardson AL. Predicting features of breast cancer with gene expression patterns. Breast Cancer Res Treat 2008; 108:191-201 (Pubitemid 351311362)
12. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001; 98:10,869-10,874 (Pubitemid 32878711)
13. Tchou JC, Wang L-P, Sargen M, Sonnad S, Tomaszewski J, Schnall M. Do triple-native breast cancers have a distinct imaging phenotype? (abstr) Breast Cancer Res Treat 2006; 100[suppl1]:S128
14. Schrading S, Kuhl CK. Mammographic, US, and MR imaging phenotypes of familial breast cancer. Radiology 2008; 246:58-70
15. Mountford CE, Doran S, Lean C, Russell P. Proton MRS can determine the pathology of human cancers with a high level of accuracy. Chem Rev 2004; 104:3677-3704
16. Mountford C, Lean C, Malycha P, Russell P. Spectroscopy provides accurate pathology on biopsy and in vivo. J Magn Reson Imaging 2006; 24:459-477 (Pubitemid 44320548)
17. Mountford CE, Doran S, Lean CL, Russell P. Cancer pathology in the year 2000. Biophys Chem 1997; 68:127-135
18. Russell P, Lean CL, Delbridge L, May GL, Dowd S, Mountford CE. Proton magnetic resonance and human thyroid neoplasia. I. Discrimination between benign and malignant neoplasms. Am J Med 1994; 96:383-388 (Pubitemid 24127277)
19. Lean CL, Delbridge L, Russell P, et al. Diagnosis of follicular thyroid lesions by proton magnetic resonance on fine needle biopsy. J Clin Endocrinol Metab 1995; 80:1306-1311
20. Barry P, Wadstrom C, Falk G, et al. What is the value of 1H MRS in detecting early malignant changes? In: Giuli R, Galmiche JP, Jamieson GC, Scarpignato C, eds. The oesophagogastric junction. Montrouge, France: John Libby, 1998:1122-1127
21. Danielsen E, Ross B. Magnetic resonance spectroscopy: diagnosis of neurological diseases. New York, NY: Marcel Dekker, 1999
22. 1H MRS at 1.5T. Eur Radiol 2005; 15:1037-1043
23. Mountford CE, Stanwell P, Ramadan S, Malycha P. Proton MRS of the breast in the clinical setting. NMR Biomed 2009; 22:54-64
24. Aboagye EO, Bhujwalla ZM. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res 1999; 59:80-84
25. Roman SA. Proton MRS study of breast cancer. (PhD thesis) Sydney, Australia: University of Sidney, 1992:184
26. Cross KJ, Holmes KT, Mountford CE, Wright PE. Assignment of acyl chain resonances from membranes of mammalian cells by two-dimensional NMR methods. Biochemistry 1984; 23:5895-5897
27. Delikatny E, Hull W, Mountford C. The effect of altering time domains and window functions in two-dimensional proton COSY spectra of biological specimens. J Magn Reson 1991; 94:563-573
28. Ernst R, Bodenhausen G, Wokaun A. Principles of nuclear magnetic resonance in one and two dimensions. Oxford, UK: Clarendon Press, 1987
29. Lean CL, Mackinnon WB, Delikatny EJ, Whitehead RH, Mountford CE. Cell-surface fucosylation and magnetic resonance spectroscopy characterization of human malignant colorectal cells. Biochemistry 1992; 31:11,095-11,105
30. Mackinnon WB, Barry PA, Malycha PL, et al. Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. Radiology 1997; 204:661-666
31. Somorjai RL, Alexander M, Baumgartner R, et al. A data-driven, flexible machine learning strategy for the classification of biomedical data. In: Dubitz ky W, Azuaje F, eds. Artificial intelligence methods and tools for systems biology. Boston, MA: Springer-Verlag and Kluwer, 2004
32. Mountford CE, Somorjai RL, Malycha P, et al. Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine-needle aspirates analysed using a statistical classification strategy. Br J Surg 2001; 88:1234-1240 (Pubitemid 34015609)
33. Lean C, Doran S, Somorjai RL, et al. Determination of grade and receptor status from the primary breast lesion by magnetic resonance spectroscopy. Technol Cancer Res Treat 2004; 3:551-556 (Pubitemid 40023544)
34. Sitter B, Lundgren S, Bathen TF, Halgunset J, Fjosne HE, Gribbestad IS. Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters. NMR Biomed 2006; 19:30-40 (Pubitemid 43250787)
35. Bathen TF, Jensen LR, Sitter B, et al. MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status. Breast Cancer Res Treat 2007; 104:181-189 (Pubitemid 47086272)
36. Sharma U, Jaganathan NR, eds. In vivo magnetic resonance spectroscopy in breast cancer. London, UK: Springer-Verlag, 2007
37. Katz-Brull R, Lavin P, Lenkinski R. Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J Natl Cancer Inst 2002; 94:1197-1203 (Pubitemid 34993869)
38. 1H MRS of normal breast and breast tumors using a dedicated double breast coil. J Magn Reson Imaging 1998; 8:1191-1197
39. Cecil KM, Schnall MD, Siegelman ES, Lenkinski RE. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat 2001; 68:45-54 (Pubitemid 32928270)
40. Jagannathan NR, Kumar M, Seenu V, et al. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 2001; 84:1016-1022 (Pubitemid 32448495)
41. Yeung DKW, Cheung HS, Tse GMK. Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy - initial results. Radiology 2001; 220:40-46
42. Jacobs MA, Barker PB, Bottomley PA, Bhujwalla Z, Bluemke DA. Proton MR spectroscopic imaging of human breast cancer: a preliminary study. J Magn Reson Imaging 2004; 19:68-75 (Pubitemid 38055731)
43. Bartella L, Morris EA, Dershaw DD, et al. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. Radiology 2006; 239:686-692 (Pubitemid 43830603)
44. Stanwell P, Mountford C. In vivo proton MR spectroscopy of the breast. RadioGraphics 2007; 27[suppl 1]:S253-S266
45. Yankeelov TE, Lepage M, Chakravarthy A, et al. Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging 2007; 25:1-13 (Pubitemid 46048940)
46. Kuroki Y, Nasu K. Advances in breast MRI: diffusion-weighted imaging of the breast. Breast Cancer 2008; 15:212-217
47. Lo GG, Ai V, Chan JK, et al. Diffusion-weighted magnetic resonance imaging of the breast lesions: first experiences at 3 T. J Comput Assist Tomogr 2009; 33:63-69
48. Boone JM, Kwan AT, Yang K, Burkett GW, Lindfors KK, Nelson TR. Computed tomography for imaging the breast. J Mammary Gland Biol Neoplasia 2006; 11:103-111
49. Lindfors KK, Boone JM, Nelson TR, Yang K, Kwan AL, Miller DF. Dedicated breast CT: initial clinical experience. Radiology 2008; 246:725-733
50. Brem RF, Schoonjans JM, Kieper DA, Majewski S, Goodman S, Civelek C. High-resolution scintimammography: a pilot study. J Nucl Med 2002; 43:909-915
51. 99mTc-sestamibi scintimammography. Semin Nucl Med 2005; 35:100-115
52. Brem RF, Floerke AC, Rapelyea JA, Teal C, Kelly T, Mathur V. Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer. Radiology 2008; 247:651-657
53. Berg WA, Weinberg I, Narayanan D, et al. High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer. Breast J 2006; 12:309-323 (Pubitemid 43989975)
54. Raylman RR, Majewski S, Smith MF, et al. The positron emission mammography/tomography breast imaging and biopsy system (PEM/PET): design, construction and phantom-based measurements. Phys Med Biol 2008; 53:637-653
55. Flexman ML, Li Y, Bur AM, et al. The design and characterization of a digital optical breast cancer imaging system. Conf Proc IEEE Eng Med Biol Soc 2008; 2008:3735-3738
56. Amoh Y, Katsuoka K, Hoffman RM. Color-coded fluorescent protein imaging of angiogenesis: the AngioMouse models. Curr Pharm Des 2008; 14:3810-3819
57. Baeten J, Haller J, Shih H, Ntziachristos V. In vivo investigation of breast cancer progression by use of an internal control. Neoplasia 2009; 11:220-227
58. Conklin MW, Provenzano PP, Eliceiri KW, Sullivan R, Keely PJ. Fluorescence lifetime imaging of endogenous fluorophores in histopathology sections reveals differences between normal and tumor epithelium in carcinoma in situ of the breast. Cell Biochem Biophys 2009; 53:145-157
59. van de Ven SM, Elias SG, van den Bosch MA, Luijten P, Mali WP. Optical imaging of the breast. Cancer Imaging 2008; 25:206-215
60. Karellas A, Vedantham S. Breast cancer imaging: a perspective for the next decade. Med Phys 2008; 35:4878-4897
61. Mountford CE, Somorjai RL, Malycha P, et al. Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine-needle aspirates analysed using statistical classification strategy. Br J Surg 2001; 88:1234-1240 (Pubitemid 34015609)
62. Weissleder R, Mahmood U. Molecular imaging. Radiology 2001:219:316-333
63. Weissleder R, Tung CH, Mahmood U, Bogdanov A Jr. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 1999; 17:375-378 (Pubitemid 29166041)
64. Brem RF, Rapelyea JA, Zisman G, et al. Occult breast cancer: scintimammography with high-resolution breast-specific gamma camera in women at high risk for breast cancer. Radiology 2005; 237:274-280 (Pubitemid 41346174)